首页
产品目录
分子砌块
按官能团
炔烃
4-(4-(3,8-二氮杂双环[3.2.1]辛-6-烯-3-基)-6,8-二氟-2-(((2-氟-四氢-1H-吡咯里嗪-7a(5H)-基)甲氧基))喹唑啉-7-基)-5-乙炔基-6-氟萘-2-胺
4-(4-(3,8-二氮杂双环[3.2.1]辛-6-烯-3-基)-6,8-二氟-2-(((2-氟-四氢-1H-吡咯里嗪-7a(5H)-基)甲氧基))喹唑啉-7-基)-5-乙炔基-6-氟萘-2-胺
4-(4-(3,8-diazabicyclo[3.2.1]oct-6-en-3-yl)-6,8-difluoro-2-((2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)quinazolin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-amine
产品编号 :
ACLUIG608
Cas No. :
2958627-18-2
包装规格
纯度
目录价
会员专享价
库存
数量
抱歉,暂无牌价信息
晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。
基础信息
CAS No.
2958627-18-2
中文名称
4-(4-(3,8-二氮杂双环[3.2.1]辛-6-烯-3-基)-6,8-二氟-2-(((2-氟-四氢-1H-吡咯里嗪-7a(5H)-基)甲氧基))喹唑啉-7-基)-5-乙炔基-6-氟萘-2-胺
英文名称
4-(4-(3,8-diazabicyclo[3.2.1]oct-6-en-3-yl)-6,8-difluoro-2-((2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)quinazolin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-amine
别名
AZD0022;2-Naphthalenamine, 4-[4-(3,8-diazabicyclo[3.2.1]oct-6-en-3-yl)-6,8-difluoro-2-[[(2R,7aS)-2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl]methoxy]-7-quinazolinyl]-5-ethynyl-6-fluoro-, (4R)-
标准英文名
4-(4-(3,8-diazabicyclo[3.2.1]oct-6-en-3-yl)-6,8-difluoro-2-((2-fluorotetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)quinazolin-7-yl)-5-ethynyl-6-fluoronaphthalen-2-amine
分子式
C3 4 H3 0 F4 N6 O
分子量
614.65
精确分子量
614.24
SMILES
FC1=C(C#C)C2=C(C3=C(F)C4=NC(OCC56N(CC(C6)F)CCC5)=NC(N7CC8C=CC(C7)N8)=C4C=C3F)C=C(N)C=C2C=C1
标准SMILES
C#CC1C2=C(C=C(N)C=C2C=CC=1F)C1=C(F)C2=NC(=NC(=C2C=C1F)N1CC2C=CC(C1)N2)OCC12CC(F)CN1CCC2
用途
AZD0022 is a selective, orally active KRASG12D inhibitor that demonstrates broad antitumor activity in CRC (colorectal cancer), PDAC, and NSCLC xenograft models; it enhances efficacy when combined with cetuximab and is currently in first-in-human clinical trials (NCT06599502).
InChIKey
HLFQZDAHMCQMND-UHFFFAOYSA-N